StockNews.com began coverage on shares of BIOLASE (NASDAQ:BIOL – Get Free Report) in a research report issued on Thursday. The brokerage set a “sell” rating on the medical technology company’s stock.

Short interest in Biolase Inc COM PAR $.001 NEW (OTC:BIOL) decreased during the last reporting period, falling from 21.03K to 9.02K. This put -% of the company's publicly available shares short.

Why Alibaba Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session Why Cutera Shares Are Trading Lower By Over 26%? Here Are Other Stocks Moving In Friday ...

Enhance your stock picks with dividend metrics like per-share dividends, yield, frequency, payout ratios, and more.